ScholarIQanswers from OpenAlex

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy

PaperCitations, authors & open-access status

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy have?

ScholarIQcitation count

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy has 177 citations in the OpenAlex counts ScholarIQ stores.

When was High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy published?

ScholarIQyear

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy has 2019 year in the ScholarIQ index.

What is the open-access status of High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

ScholarIQoa status

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy has bronze oa status in the ScholarIQ index.

What is the DOI of High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

ScholarIQdoi

The DOI for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is on the source record.

What is the PMID of High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

ScholarIQpmid

The PMID for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is on the source record.

What is the OpenAlex record for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy?

ScholarIQopenalex

The OpenAlex for High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial